Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ANB 004 - Biocad

Next Previous
X
Search
Drug Profile

ANB 004 - Biocad

Alternative Names: ANB-004 - Biocad

Latest Information Update: 02 Mar 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biocad
  • Class Spinal muscular atrophy gene therapies
  • Mechanism of Action Gene transference; Survival of motor neuron 1 protein replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Spinal muscular atrophy

Most Recent Events

  • 28 Feb 2023 Phase-I/II clinical trials in Spinal muscular atrophy (In infants, In neonates) in Russia (IV) (NCT05747261)
  • 01 Aug 2022 ANB 004 - Biocad is available for licensing as of 01 Aug 2022. https://biocadglobal.com/partnering
  • 01 Aug 2022 Preclinical trials in Spinal muscular atrophy in Russia (IV) (Biocad pipeline, August 2022)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top